Literature DB >> 12071811

Intensity-modulated radiation therapy.

Thomas E Goffman1, Eli Glatstein.   

Abstract

Intensity-modulated radiation therapy (IMRT) is an increasingly popular technical means of tightly focusing the radiation dose around a cancer. As with stereotactic radiotherapy, IMRT uses multiple fields and angles to converge on the target. The potential for total dose escalation and for escalation of daily fraction size to the gross cancer is exciting. The excitement, however, has greatly overshadowed a range of radiobiological and clinical concerns.

Entities:  

Mesh:

Year:  2002        PMID: 12071811     DOI: 10.1667/0033-7587(2002)158[0115:imrt]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

Review 1.  [Optimizing the use of radiotherapy with IMRT and image guided location of advanced prostate cancer].

Authors:  F Lohr; M Fuss; U Tiefenbacher; M Siegsmund; S Mai; J M Kunnappallil; B Dobler; P Alken; F Wenz
Journal:  Urologe A       Date:  2004-01       Impact factor: 0.639

2.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

Review 3.  Chemoradiation for gastric cancer: controversies, updates and novel techniques.

Authors:  M Fan; W Hu; Z Zhang
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

Review 4.  Hypoxia imaging-directed radiation treatment planning.

Authors:  J G Rajendran; K R G Hendrickson; A M Spence; M Muzi; K A Krohn; D A Mankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

Review 5.  Current adjuvant treatment modalities for gastric cancer: From history to the future.

Authors:  Leyla Kilic; Cetin Ordu; Ibrahim Yildiz; Fatma Sen; Serkan Keskin; Rumeysa Ciftci; Kezban Nur Pilanci
Journal:  World J Gastrointest Oncol       Date:  2016-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.